ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 2,925.00
-15.00 (-0.51%)
At close: Oct 23, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 267.35 billion as of October 23, 2026. It is the 20,600th most valuable company in the world and the 672nd biggest in South Korea. Its market cap has decreased by 39.00% in one year.
Market Cap
267.35B
Enterprise Value
174.22B
Revenue
n/a
Global Rank
Country Rank
#672 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 267.35B, a decrease of -51.17%. That is a compound annual growth rate of -39.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 267.35B | -72.31% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC WellBeing | 201.65B |
| HEM Pharma | 200.77B |
| DAE HWA Pharmaceutical | 182.93B |
| Vivozon Pharmaceutical | 174.48B |
| NOVAREX | 164.45B |
| CellBion | 152.41B |
| Kyung Dong Pharmaceutical | 143.57B |
| HYUNDAI BIOLAND | 129.75B |